AVITA Medical to Announce 2023 Financial Results and Discuss Regenerative Medicine

AVITA Medical, Inc. will announce its fourth quarter and full year 2023 financial results after the close of the U.S. financial markets on February 22, 2024. The company's CEO and CFO will host a conference call and webcast to discuss financial results, business highlights, and future revenue guidance. AVITA Medical specializes in regenerative medicine, with the RECELL System approved for skin restoration and PermeaDerm, a Biosynthetic Wound Matrix, marketed in the United States.